Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Adicet Bio, Inc. - Common Stock (NQ:ACET)

7.950 -0.550 (-6.47%)
Streaming Delayed Price Updated: 2:24 PM EST, Jan 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Adicet Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Appoints Lloyd Klickstein, M.D., Ph.D. to the Board of Directors
From Adicet Bio, Inc.
Via Business Wire
News headline image
ACET Stock Earnings: Adicet Bio Beats EPS for Q2 2024 ↗
ACET stock results show that Adicet Bio beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
Adicet Reports Second Quarter 2024 Financial Results and Provides Business Updates
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio: Q4 Earnings Insights ↗
 
Via Benzinga
News headline image
Adicet Bio to Participate in Upcoming Investor Conferences
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Receives FDA Fast Track Designation for ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma
From Adicet Bio, Inc.
Via Business Wire
News headline image
Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024 ↗
These are the biotech stocks under $10 that are attractively valued and have potential catalysts in the form of positive clinical trials news 
Via InvestorPlace
News headline image
Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference
From Adicet Bio, Inc.
Via Business Wire
News headline image
ACET Stock Earnings: Adicet Bio Beats EPS for Q1 2024 ↗
ACET stock results show that Adicet Bio beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness ↗
Although speculation can be bad for your blood pressure, these compelling penny stocks have some strong endorsements. 
Via InvestorPlace
News headline image
ACET Stock Earnings: Adicet Bio Meets EPS for Q4 2023 ↗
ACET stock results show that Adicet Bio met analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
From Adicet Bio, Inc.
Via Business Wire
News headline image
3 High-Risk Stocks That Could Pay Off in the Millions ↗
With the S&P 500 at record highs, betting on these high-risk stocks that could pay off is a tantalizing prospect at this time. 
Via InvestorPlace
Topics Stocks
News headline image
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
7 Top-Tier Penny Stocks for a Smart Bet ↗
Unlock value in penny stocks amid bullish S&P 500 trends and shifting monetary policies, focusing on businesses with solid drivers 
Via InvestorPlace
Topics Stocks
News headline image
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory ↗
Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.